Common Causes of Syncope in ESRD Patients
In end-stage renal disease patients, syncope is most commonly caused by medication-related hypotension, volume depletion from dialysis, orthostatic hypotension, cardiac arrhythmias, and electrolyte disturbances—with the risk substantially elevated compared to the general population.
Primary Mechanisms in ESRD
Volume and Medication-Related Causes (Most Common)
ESRD patients face a uniquely elevated syncope risk, with lower eGFR and higher albuminuria independently associated with increased syncope incidence in a stepwise manner 1. The adjusted hazard ratio reaches 1.67 for eGFR <30 compared to eGFR ≥90, demonstrating that advanced kidney disease itself is a major risk factor 1.
Medication-induced hypotension is particularly prevalent in ESRD patients who typically require multiple antihypertensive agents, diuretics, and other cardiovascular medications 2. The 2017 ACC/AHA/HRS guidelines emphasize that syncope from medications becomes especially problematic in older adults with multiple comorbidities—a description that fits most ESRD patients 2. Key offending drug classes include:
- Diuretics (causing volume depletion)
- Vasodilators and venodilators
- Negative chronotropes (beta-blockers, calcium channel blockers)
- Sedatives 2
Dehydration and intravascular volume depletion occur frequently in dialysis patients, particularly during or immediately after hemodialysis sessions when rapid fluid removal can precipitate hypotension 2. This is exacerbated by the inability of ESRD patients to maintain normal fluid homeostasis.
Orthostatic Hypotension
Orthostatic hypotension is a critical mechanism in ESRD, resulting from:
- Autonomic dysfunction (uremic neuropathy)
- Impaired peripheral vasoconstriction
- Reduced intravascular volume from dialysis
- Medication effects 2, 3
The guidelines recommend checking orthostatic vital signs in lying and sitting positions, immediately upon standing, and after 3 minutes upright 4.
Cardiac Causes (Higher Risk)
ESRD patients have substantially elevated cardiovascular disease burden, making cardiac syncope more likely and more dangerous. After a syncope event, ESRD patients with eGFR <30 have an adjusted HR of 1.62 for the composite outcome of MI, stroke, and death compared to those with eGFR ≥90 1.
Cardiac causes include:
- Arrhythmias (both brady- and tachyarrhythmias from electrolyte disturbances, particularly hyperkalemia and hypocalcemia)
- Structural heart disease (LV hypertrophy, cardiomyopathy, valvular disease—all common in ESRD)
- Ischemic heart disease 4
Historical features suggesting cardiac syncope in ESRD patients:
- Brief or absent prodrome
- Syncope during exertion or in supine position
- Palpitations before loss of consciousness
- Known structural heart disease or reduced ventricular function 4
Dialysis-Specific Causes
Central venous occlusion from dialysis access can cause intracranial venous congestion leading to syncope, dizziness, and neurological symptoms 5. This is an often-overlooked cause that requires venography for diagnosis and can be treated with angioplasty or stenting 5.
Dialysis disequilibrium syndrome and rapid electrolyte shifts during hemodialysis can precipitate syncope.
Critical Pitfalls
The most dangerous pitfall is assuming syncope in ESRD is benign or simply volume-related when cardiac causes carry significantly worse prognosis. The annual mortality reaches 18-33% for cardiac syncope versus 0-12% for non-cardiac causes 6.
A 12-lead ECG is mandatory in all ESRD patients with syncope to identify arrhythmias, conduction abnormalities, or signs of structural heart disease 4. Look specifically for:
- Bradyarrhythmias with sinus pauses or high-grade AV block
- Prolonged QT interval
- LV hypertrophy voltage criteria
- Intraventricular conduction disturbances
- Signs of hyperkalemia (peaked T waves, widened QRS)
Do not reflexively increase sodium and fluid intake as recommended for typical orthostatic syncope—this treatment is explicitly contraindicated in CKD patients per guidelines 2.
Management Approach
Reducing or withdrawing hypotension-causing medications is beneficial (Class IIa recommendation) but requires close supervision due to risks of worsening supine hypertension or unmasking arrhythmias 2. Consider drug-drug interactions given the polypharmacy burden in ESRD.
For acute dehydration-related syncope, fluid resuscitation via oral or IV bolus is recommended (Class I), but must be carefully balanced against volume overload risk in ESRD 2.
Dialysis regimen adjustment may be necessary—slower ultrafiltration rates, cooler dialysate temperature, or more frequent shorter sessions can reduce intradialytic hypotension.
Cardiac evaluation is essential when history, exam, or ECG suggest cardiac etiology, given the substantially elevated mortality risk in this population 1.